Skip to main content
. 2023 May 25;279(1):138–146. doi: 10.1097/SLA.0000000000005924

FIGURE 1.

FIGURE 1

Flowchart of patients selected for R-NSM, C-NSM or E-NMS, and IPBR for surgical treatment of breast cancer. This is an open-label, nonrandomized, prospective, multicenter trial comparing 3 cohorts of patients (R-NSM vs C-NSM or E-NSM and IPBR).